Madam Chair, I have an amendment at the desk. First of all, let me begin by recognizing my friend, Chairman Wolf, for his long and distinguished career in public service--a role model for all of us. Let me say also how impressed all of us…
Madam Chair, I have an amendment at the desk.
First of all, let me begin by recognizing my friend, Chairman Wolf, for his long and distinguished career in public service--a role model for all of us. Let me say also how impressed all of us are with the teamwork of Chairman Wolf's and of Ranking Member Fattah's in putting together this piece of legislation. I am giving it my highest endorsement here.
Madam Chair, I rise today to offer an amendment about an issue that is of grave concern to us in upstate New York, which is of the heroin and opiate epidemic that is going on.
From the stories I have read, this is actually an issue across our country. I will note that the Governor of Vermont spent the time in his State of the State to address this issue. We certainly have to do more on this score.
I have convened meetings in which I have had an opportunity to listen very carefully to district attorneys, to law enforcement professionals, to medical professionals, and to the families of those affected. Without any doubt, we are going to have to do more to address this issue. I see it in three basic categories. One is doing more on prevention. The second is enforcement. The third is treatment. Treatment is handled in the Labor-HHS bill, and I look forward to our addressing that in the weeks to come. Tonight, we can address prevention and enforcement.
I do want to commend the committee, and I do want to read of some specific areas of the bill in which the committee, I think, has done great on this issue.
In DEA Language:
Prescription drug and heroin abuse--the committee is
extremely concerned about the continued threat posed by
prescription drug abuse, as well as about the resurgence of
heroin abuse and overdoses that appear connected to the
enforcement of laws against prescription drug diversion. The
committee has included in its recommendation funding to
support the enhancement of DEA's investigative efforts to
deal with these growing threats and directs DEA to report to
the committee no later than 60 days after the enactment of
this Act on the numbers of actual and estimated heroin
investigations in fiscal years 2013 through 2015, the amounts
and street value of heroin associated with such
investigations and prosecutions resulting from
investigations.
In the DOJ General Administration:
Heroin--the committee notes with concern the increase in
heroin abuse. The Department shall report no later than 90
days after the enactment of this act on potential ways to
address this problem, such as prevention, law enforcement
strategies, prescription drug disposal site expansion, and
other evidence-based approaches.
Then, finally, in Organized Crime Drug Enforcement Task Force:
Heroin--the recent surge in heroin use, overdose deaths,
and trafficking volumes shows it to be one of the gravest
problems now facing law enforcement and the drug treatment
community. DEA noted in its 2013 threat assessment a trend of
users switching to heroin from prescription drug abuse as one
explanation for a rise in overdose deaths and warned that
persons addicted to opioid prescription pills now find highly
pure heroin easier and cheaper to obtain. The committee urges
the Department to intensify its use of task forces to address
this disturbing trend.
I commend the committee for their work on this.
I rise to offer an amendment to increase, by $4 million, the funding for the account that addresses the Organized Crime Drug Enforcement Task Force. This will help our country--and my district in particular-- in dealing with high-level traffickers and gangs that are selling heroin and opioids. I think this will help.
It will be part of an overarching strategy, and I think it synchronizes with the committee, so I urge my colleagues to support the amendment.
I yield back the balance of my time.